ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Zaltenibart Biosimilar - Anti-MASP1 Antibody - BSA and Azide free (A340751)

Recombinant chimeric monoclonal antibody to MASP1 for use as a research grade Zaltenibart biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Zaltenibart Biosimilar - Anti-MASP1 Antibody - BSA and Azide free
Description
Recombinant chimeric monoclonal antibody to MASP1 for use as a research grade Zaltenibart biosimilar.
Applications
ELISA, Flow Cytometry, Functional Studies, in vivo Research
Reactivity
Human
Host
Chimeric
Clonality
Monoclonal
Isotype
IgG4
Conjugate

Unconjugated

Purity
The purity of this Biosimilar is >95%, as determined by SDS-PAGE.
Product Form
Liquid
Formulation
Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.
Storage
Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).
Synonyms
Complement factor MASP-3, Complement-activating component of Ra-reactive factor, CRARF, CRARF1, Mannan-binding lectin serine protease 1, Mannose-binding lectin-associated serine protease 1, Mannose-binding protein-associated serine protease, MASP-1, PRSS5, Ra-reactive factor serine protease p100, RaRF, Serine protease 5
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Zaltenibart Biosimilar - Anti-MASP1 Antibody - BSA and Azide free (A340751)? Please let us know so that we can list the citation on this page.

Alternative products to Zaltenibart Biosimilar - Anti-MASP1 Antibody - BSA and Azide free (A340751)

Proteins predicted to interact with MASP1

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.8% Relevancy Score
99% Relevancy Score
98.6% Relevancy Score
98% Relevancy Score
94.2% Relevancy Score
93.6% Relevancy Score
85.1% Relevancy Score